ArticleJournal of advanced research2026
Reactions of N-heterocyclic carbenes with nitrobenzenes: harnessing NHCs as synthetic building blocks.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionQuinazolin-4-one is a privileged scaffold in drugs with broad clinical applications. Conventionally, an o-amino group was generally needed to be pre-installed on the benzoic acid-derived starting materials for the efficient condensation reactions towards quinazolin-4-ones. The application of benzene derivatives without requisite amino and / or carbonyl groups as the quinazolin-4-one starting materials has not been disclosed. Therefore, we report herein the fabrication of NHC molecules with nitrobenzenes for facile access to quinazolin-4-one derivatives.
objectivesTo develop an unprecedented synthetic method utilizing nitrobenzenes and N-heterocyclic carbene (NHC) molecules, to elucidate the novel reaction mechanism through experimental and computational studies, to synthesize a series of quinazolin-4-one derivatives, and to evaluate their in vitro antibacterial activity.
methodsA synthetic method involving nitrobenzenes and NHC molecules was developed. The novel reaction mechanism was elucidated through isotopic labeling experiments and computational studies, and a series of quinazolin-4-one derivatives were synthesized. The synthesized compounds were evaluated for in vitro antifungal activity against four plant pathogens using the mycelial growth rate method.
resultsWe report for the first time an unprecedented synthetic method involving nitrobenzene and NHC molecules. The nitrobenzene substrate acts as a novel type of NHC acceptor, enabling a condensation reaction with the NHC molecule through a multi-step nucleophilic addition/rearrangement/dehydration cascade process. This conceptually novel reaction mechanism has been thoroughly investigated through experimental and computational studies. A variety of substituents with different electronic properties are tolerated on both the nitrobenzene and NHC reactants. A series of quinazolin-4-one products can be readily accessed using the current synthetic strategy, and they exhibit promising antifungal activity in plant protection.
conclusionWe have developed a conceptually novel incorporation reaction between nitrobenzenes and NHC molecules. Synthesized compound 13 exhibited broad-spectrum antifungal activity, providing a basis for its development potential as a new framework for pesticide design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.